Klaus K. Wilgenbus
Geen lopende functies
Profiel
Klaus K.
Wilgenbus served as the Chief Executive Officer & Director at Karolinska Development AB from 2014 to 2014.
He also held the position of Chief Executive Officer at Northern Data AG from 2016 to 2017.
Prior to these roles, he was the Chief Executive Officer & Managing Director at Allecra Therapeutics GmbH and a Director at Actimis Pharmaceuticals, Inc. Dr. Wilgenbus also worked at Boehringer Ingelheim GmbH as the Corporate SVP-Business Development & Licensing.
He obtained his doctorate degree from RWTH Aachen University in 1989.
Eerdere bekende functies van Klaus K. Wilgenbus
| Bedrijven | Functie | Einde |
|---|---|---|
| NORTHERN DATA AG | Algemeen Directeur | 23-11-2017 |
| KAROLINSKA DEVELOPMENT AB | Algemeen Directeur | 15-10-2014 |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Algemeen Directeur | - |
Actimis Pharmaceuticals, Inc.
 Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | - |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - |
Opleiding van Klaus K. Wilgenbus
| RWTH Aachen University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| NORTHERN DATA AG | Technology Services |
| Bedrijven in privébezit | 3 |
|---|---|
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Actimis Pharmaceuticals, Inc.
Actimis Pharmaceuticals, Inc. BiotechnologyHealth Technology Actimis Pharmaceuticals, Inc. provides pharmaceutical research and development services. it focuses on the development of small therapeutics for respiratory and inflammatory disorders. The company was founded by Kevin B. Bacon in November 2004 and is headquartered in San Diego, CA. | Health Technology |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Health Technology |
